Overview

A Study to Evaluate Effectiveness and Safety of Deucravacitinib in Participants With Non-Pustular Palmoplantar and Genital Psoriasis

Status:
Recruiting

Trial end date:
2026-04-22

Target enrollment:

Participant gender:

Summary

The purpose of this study is to measure the safety and effectiveness of deucravatinib in participants with non-pustular palmoplantar psoriasis and genital psoriasis.

Phase:

Phase 4

Details

Lead Sponsor:

Bristol-Myers Squibb

Treatments:

Deucravacitinib